← Eichor
Study identifier: NCT06565169 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Improving PCP Advance Care Planning for People With ADRD

Condition: Alzheimer Disease · Dementia · Alzheimer's Disease (Incl Subtypes)  ·  Sponsor: University of Pittsburgh

PhaseNA
Planned participants120
Who can joinAll sexes, 18 Years to 99 Years
Healthy volunteersNo

About this study

This study will test the Dementia Advance Care Planning (AD ACP) Toolkit intervention to usual care in facilitating goals of care (GOC) discussions between People Living with Dementia (PLwD) and primary care team members over an 18-month period. The primary outcome is to assess the frequency and quality of GOC discussions with PLwD. Secondary outcomes include the identification of preferred surrogates, assessment of decisional capacity, and the completion of portable ACP orders. This randomized clinical trial aims to determine if the AD ACP Toolkit can enhance ACP practices and improve care planning outcomes for PLwD compared to the standard care approach.

This description comes directly from the study's public registry record.

Talk to the study team

Christine E. Kistler, MD, MASc  ·  412-286-2507  ·  KISTLERC@pitt.edu

Janelle J. Christensen, PhD, MPH  ·  412-692-2481  ·  jjc157@pitt.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of North Carolina, Chapel HillChapel Hill, North Carolina, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06565169